News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Don’t miss the ESMO Sarcoma and Rare Cancers Congress 2025!
ESMO/X
Jan 16, 2025, 22:19

Don’t miss the ESMO Sarcoma and Rare Cancers Congress 2025!

ESMO shared on LinkedIn:

“Don’t miss the ESMO Sarcoma and Rare Cancers Congress 2025!
Join top experts to explore innovative treatments and deepen your understanding of rare cancers.

Early registration rates expire 22 January —register now and save. ”

Additional information.

cancer ESMO OncoDaily Oncology sarcoma
Special Coverage
Insight
May 9, 2025, 13:17
Angelo Dipasquale: Exploring the Role of ADCs in CNS malignancies and Primary Brain Tumors
Insight
May 9, 2025, 13:06
Sampson Chinonso Ipiankama: The Role of Men in Early Care-seeking for Ovarian Cancer in LMICs
Insight
May 9, 2025, 13:01
Ahmed Alanazi: T-DXd Achieves Primary Endpoint in Early Breast Cancer Neoadjuvant Trial (DB-11)
Science
May 9, 2025, 12:49
The Evolving Therapeutic Revolution in Adult Acute Lymphoblastic Leukemia
Drugs
May 9, 2025, 12:42
Penpulimab: What patients need to know?
Blog
May 9, 2025, 12:36
Avisek Banerjee: Proud to support Triparna Sen for 2025 IASLC Board of Directors (Basic Science) ballot
Science
May 9, 2025, 12:28
Aaron Goodman Highlights IL18-Secreting CAR T Therapy for Refractory Lymphoma
Blog
May 9, 2025, 12:26
Caryn Lerman: Join us for the 3rd Annual Cancer Research Day
Blog
May 9, 2025, 12:18
Navneet Singh: Overcoming Challenges and Embracing Novel Technologies in Lung Cancer Screening
Blog
May 9, 2025, 12:14
Aakash Desai Highlights New Study on BRAF-Mutated NSCLC: Personalization Over One-Size-Fits-All
History
May 9, 2025, 11:55
Celebrating AACR's Founding Anniversary - From 11 Prominent Scientists to 59,000 Research Leaders
Blog
May 9, 2025, 11:53
Amol Akhade Discusses POTOMAC Phase 3 Results in High-Risk NMIBC